SequelSEC

BIO-PATH HOLDINGS, INC. BPTH

Pharmaceutical Preparations · CIK 0001133818 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$37.00K
Fiscal year ended 2017-12-31
Operating income
-$8.97M
Fiscal year ended 2017-12-31
Free cash flow
-$8.50M
Fiscal year ended 2017-12-31

Valuation, from the filing

Public float$5.04MMarket value of stock held by non-affiliates, as stated on the cover page for 2024-06-30
Float per share$0.61Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-06-30, not today.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth-100.0%0th
Current ratio1.61x24th

BIO-PATH HOLDINGS, INC. (BPTH) reported revenue of $37.00K and net income of -$7.02M for the fiscal year ended 2017-12-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from BIO-PATH HOLDINGS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

BIO-PATH HOLDINGS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2017-12-31
Revenue$37.00K
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$8.97M
Net income-$7.02M
Research & development$5.48M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$3.52M
Selling & marketingUnavailable

Balance

BIO-PATH HOLDINGS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2017-12-31
Cash & equivalentsUnavailable
Total assets$8.86M
Current assets$7.44M
Total liabilities$791.00K
Current liabilities$791.00K
Total equity incl. NCI$8.07M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$52.00K

Cash flow

BIO-PATH HOLDINGS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2017-12-31
Operating cash flow-$7.96M
Capital expenditures$538.00K
Investing cash flow-$538.00K
Financing cash flowUnavailable
Net change in cashUnavailable
Stock-based compensation$793.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

BIO-PATH HOLDINGS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2017-12-31
Free cash flow-$8.50M
Gross marginUnavailable
Operating margin-24232.4%
FCF margin-22959.5%
SBC / revenue2143.2%
Current ratio9.40x
Revenue YoY growth184.6%
Net margin-18981.1%
R&D / revenue14810.8%
CapEx / revenue1454.1%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BPTH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-05-20View SEC filing
10-Q · Filed 2026-01-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-03-27View SEC filing
10-Q · Filed 2024-11-14View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.